U.S. Markets closed
  • S&P Futures

    3,805.00
    -11.75 (-0.31%)
     
  • Dow Futures

    31,183.00
    -53.00 (-0.17%)
     
  • Nasdaq Futures

    12,621.00
    -60.75 (-0.48%)
     
  • Russell 2000 Futures

    2,194.00
    -11.80 (-0.53%)
     
  • Crude Oil

    61.16
    -0.12 (-0.20%)
     
  • Gold

    1,712.30
    -3.50 (-0.20%)
     
  • Silver

    26.26
    -0.13 (-0.48%)
     
  • EUR/USD

    1.2058
    -0.0009 (-0.0723%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • Vix

    26.67
    +2.57 (+10.66%)
     
  • GBP/USD

    1.3937
    -0.0015 (-0.1101%)
     
  • USD/JPY

    107.0780
    +0.0760 (+0.0710%)
     
  • BTC-USD

    51,524.76
    +2,847.13 (+5.85%)
     
  • CMC Crypto 200

    1,029.81
    +41.71 (+4.22%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,114.80
    -444.30 (-1.50%)
     

Emergent Biosolutions: 4Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Thursday reported fourth-quarter profit of $185.4 million.

The Gaithersburg, Maryland-based company said it had profit of $3.44 per share. Earnings, adjusted for one-time gains and costs, came to $3.67 per share.

The biopharmaceutical company posted revenue of $583 million in the period.

For the year, the company reported profit of $305.1 million, or $5.67 per share. Revenue was reported as $1.56 billion.

Emergent Biosolutions shares have risen 31% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $117.06, a rise of 84% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS